Challenges and common sense of PS≥2 patients with non-small cell lung cancer
- VernacularTitle:PS≥2的非小细胞肺癌的共识和挑战
- Author:
Xiangyun YE
;
Shun LU
- Publication Type:Journal Article
- Keywords:
Performance status;
Non-small cell lung cancer;
Anti EGFR;
Anti VEGFR;
Target therapy
- From:
Cancer Research and Clinic
2000;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
The performance status(PS)≥2 patients with non-small cell lung cancer(NSCLC) are short of effective management.The phase Ⅱ/Ⅲ clinical trails of target therapy of anti EFGR of VEGFR have already got promise results.This article expatiates the actuality and development of the chemotherapy and novel target therapy for the PS≥2 patients with NSCLC.
